|
|
Volumn 102, Issue 15, 2010, Pages 1110-1111
|
|
Beyond PARP inhibitors: agents in pipelines target DNA repair mechanisms.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 IODO 3 NITROBENZAMIDE;
4-IODO-3-NITROBENZAMIDE;
ANTINEOPLASTIC AGENT;
BENZAMIDE DERIVATIVE;
DNA METHYLTRANSFERASE;
ENZYME INHIBITOR;
MGMT PROTEIN, HUMAN;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
OLAPARIB;
PARP1 PROTEIN, HUMAN;
PHTHALAZINE DERIVATIVE;
PIPERAZINE DERIVATIVE;
POLYDEOXYRIBONUCLEOTIDE SYNTHASE;
TUMOR SUPPRESSOR PROTEIN;
ANIMAL;
CLINICAL TRIAL;
DNA DAMAGE;
DNA REPAIR;
DRUG ANTAGONISM;
DRUG EFFECT;
GENETICS;
HETEROZYGOTE;
HUMAN;
MUTATION;
NOTE;
TUMOR SUPPRESSOR GENE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BENZAMIDES;
CLINICAL TRIALS AS TOPIC;
DNA DAMAGE;
DNA MODIFICATION METHYLASES;
DNA REPAIR;
DNA REPAIR ENZYMES;
ENZYME INHIBITORS;
GENES, BRCA1;
GENES, BRCA2;
HETEROZYGOTE;
HUMANS;
MUTATION;
PHTHALAZINES;
PIPERAZINES;
POLY(ADP-RIBOSE) POLYMERASES;
TUMOR SUPPRESSOR PROTEINS;
|
|
EID: 77955955989
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djq294 Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|
